Growing Need Erodes NIH Equipment Funds

Recognizing that a lack of funds for purchase of equipment can hamper research in the life sciences, the Division of Research Resources of the National Institutes of Health implemented the Biomedical Research Support Shared Instrumentation Grant (SIG) program in 1982 to help institutions buy new instruments and upgrade older equipment. Unfortunately, the problem that the granting scheme sought to alleviate appears to be getting more burdensome. In 1989, the SIG program received 407 applicati

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Recognizing that a lack of funds for purchase of equipment can hamper research in the life sciences, the Division of Research Resources of the National Institutes of Health implemented the Biomedical Research Support Shared Instrumentation Grant (SIG) program in 1982 to help institutions buy new instruments and upgrade older equipment.

Unfortunately, the problem that the granting scheme sought to alleviate appears to be getting more burdensome. In 1989, the SIG program received 407 applications—almost twice the number it received in its inaugural year. The funds requested, which had risen steadily from $39.1 million in 1982 to $64.6 million in 1988, swelled to $105.4 million in 1989 as the increased number of applicants requested more money. SIG’s budget, however, has not increased to meet the growing need, and, according to Marjorie Tingle, director of the Biomedical Research Support Grant program, the budget will probably not grow in the future.

“The budget ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies